These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16431232)

  • 1. Resuscitative treatments on 1,4-butanediol mortality in mice.
    Carai MA; Colombo G; Quang LS; Maher TJ; Gessa GL
    Ann Emerg Med; 2006 Feb; 47(2):184-9. PubMed ID: 16431232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice.
    Carai MA; Colombo G; Gessa GL
    Ann Emerg Med; 2005 Jun; 45(6):614-9. PubMed ID: 15940094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection by the GABAB receptor antagonist, SCH 50911, of gamma-hydroxybutyric acid-induced mortality in mice.
    Carai MA; Colombo G; Gessa GL
    Eur J Pharmacol; 2004 Oct; 503(1-3):77-80. PubMed ID: 15496299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats.
    Carai MA; Quang LS; Atzeri S; Lobina C; Maccioni P; Orrù A; Gessa GL; Maher TJ; Colombo G
    Brain Res Brain Res Protoc; 2005 Jul; 15(2):75-8. PubMed ID: 15886053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-methylpyrazole decreases 1,4-butanediol toxicity by blocking its in vivo biotransformation to gamma-hydroxybutyric acid.
    Quang LS; Desai MC; Shannon MW; Woolf AD; Maher TJ
    Ann N Y Acad Sci; 2004 Oct; 1025():528-37. PubMed ID: 15542758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of gamma-hydroxybutyrate in striatal microdialysates following peripheral 1,4-butanediol administration in rats.
    Kapadia R; Böhlke M; Maher TJ
    Life Sci; 2007 Feb; 80(11):1046-50. PubMed ID: 17188717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the antiabsence effects of SCH 50911, a GABA-B receptor antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models.
    Hosford DA; Wang Y; Liu CC; Snead OC
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1399-403. PubMed ID: 7562514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of GABA(B) receptors by chronic administration of the GABA(B) receptor antagonist SCH 50,911.
    Pibiri F; Carboni G; Carai MA; Gessa GL; Castelli MP
    Eur J Pharmacol; 2005 May; 515(1-3):94-8. PubMed ID: 15893746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid.
    Carai MA; Colombo G; Reali R; Serra S; Mocci I; Castelli MP; Cignarella G; Gessa GL
    Eur J Pharmacol; 2002 Apr; 441(3):157-63. PubMed ID: 12063087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment of CD-1 mice with 4-methylpyrazole blocks toxicity from the gamma-hydroxybutyrate precursor, 1,4-butanediol.
    Quang LS; Shannon MW; Woolf AD; Desai MC; Maher TJ
    Life Sci; 2002 Jul; 71(7):771-8. PubMed ID: 12074936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers.
    Thai D; Dyer JE; Jacob P; Haller CA
    Clin Pharmacol Ther; 2007 Feb; 81(2):178-84. PubMed ID: 17192771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines.
    Quang LS; Colombo G; Lobina C; Maccioni P; Orru A; Gessa GL; Maher TJ; Carai MA
    Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme and receptor antagonists for preventing toxicity from the gamma-hydroxybutyric acid precursor 1,4-butanediol in CD-1 mice.
    Quang LS; Desai MC; Kraner JC; Shannon MW; Woolf AD; Maher TJ
    Ann N Y Acad Sci; 2002 Jun; 965():461-72. PubMed ID: 12105121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382.
    van Nieuwenhuijzen PS; McGregor IS; Chebib M; Hunt GE
    Neuroscience; 2014 Sep; 277():700-15. PubMed ID: 25088910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone.
    Carai MA; Lobina C; Maccioni P; Cabras C; Colombo G; Gessa GL
    J Pharmacol Sci; 2008 Feb; 106(2):199-207. PubMed ID: 18270475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gamma-Hydroxybutyric acid (GHB) suppresses alcohol's motivational properties in alcohol-preferring rats.
    Maccioni P; Pes D; Fantini N; Carai MA; Gessa GL; Colombo G
    Alcohol; 2008 Mar; 42(2):107-13. PubMed ID: 18358989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-Hydroxybutyrate (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion.
    Sadasivan S; Maher TJ; Quang LS
    Ann N Y Acad Sci; 2006 Aug; 1074():537-44. PubMed ID: 17105951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence.
    Wu Y; Ali S; Ahmadian G; Liu CC; Wang YT; Gibson KM; Calver AR; Francis J; Pangalos MN; Carter Snead O
    Neuropharmacology; 2004 Dec; 47(8):1146-56. PubMed ID: 15567424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.